These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 19226610)
1. RET-mediated gene expression pattern is affected by isoform but not oncogenic mutation. Hickey JG; Myers SM; Tian X; Zhu SJ; V Shaw JL; Andrew SD; Richardson DS; Brettschneider J; Mulligan LM Genes Chromosomes Cancer; 2009 May; 48(5):429-40. PubMed ID: 19226610 [TBL] [Abstract][Full Text] [Related]
2. Transcriptome analysis in mouse tumors induced by Ret-MEN2/FMTC mutations reveals subtype-specific role in survival and interference with immune surveillance. Engelmann D; Koczan D; Ricken P; Rimpler U; Pahnke J; Li Z; Pützer BM Endocr Relat Cancer; 2009 Mar; 16(1):211-24. PubMed ID: 18984779 [TBL] [Abstract][Full Text] [Related]
3. A model for GFR alpha 4 function and a potential modifying role in multiple endocrine neoplasia 2. Vanhorne JB; Andrew SD; Harrison KJ; Taylor SA; Thomas B; McDonald TJ; Ainsworth PJ; Mulligan LM Oncogene; 2005 Feb; 24(6):1091-7. PubMed ID: 15592530 [TBL] [Abstract][Full Text] [Related]
4. Cellular effects of imatinib on medullary thyroid cancer cells harboring multiple endocrine neoplasia Type 2A and 2B associated RET mutations. de Groot JW; Plaza Menacho I; Schepers H; Drenth-Diephuis LJ; Osinga J; Plukker JT; Links TP; Eggen BJ; Hofstra RM Surgery; 2006 Jun; 139(6):806-14. PubMed ID: 16782438 [TBL] [Abstract][Full Text] [Related]
5. [Neural crest and multiple endocrinopathies]. Pasini A; Michiels FM; Chappuis-Flament S; Geneste O; Rossel M; Fournier L; Feunteun J; Lenoir G; Schuffenecker I; Billaud M C R Seances Soc Biol Fil; 1996; 190(5-6):557-67. PubMed ID: 9074721 [TBL] [Abstract][Full Text] [Related]
6. Molecular implications of RET mutations for pheochromocytoma risk in multiple endocrine neoplasia 2. Gujral TS; Mulligan LM Ann N Y Acad Sci; 2006 Aug; 1073():234-40. PubMed ID: 17102091 [TBL] [Abstract][Full Text] [Related]
7. [The RET gene in multiple endocrine neoplasia type 2 (MEN 2)]. Ito T; Shirahama S; Ogura K; Yamamoto S; Takami H Nihon Rinsho; 2004 May; 62(5):883-8. PubMed ID: 15148813 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the role of RET polymorphisms/haplotypes as modifier loci for MEN 2, and analysis of the correlation with the type of RET mutation in a series of Spanish patients. Fernández RM; Navarro E; Antiñolo G; Ruiz-Ferrer M; Borrego S Int J Mol Med; 2006 Apr; 17(4):575-81. PubMed ID: 16525712 [TBL] [Abstract][Full Text] [Related]
9. Molecular genetics and phenomics of RET mutations: Impact on prognosis of MTC. Frank-Raue K; Rondot S; Raue F Mol Cell Endocrinol; 2010 Jun; 322(1-2):2-7. PubMed ID: 20083156 [TBL] [Abstract][Full Text] [Related]
10. Double germline mutations in the RET Proto-oncogene in MEN 2A and MEN 2B kindreds. Dvorakova S; Vaclavikova E; Ryska A; Cap J; Vlcek P; Duskova J; Kodetova D; Holub V; Novak Z; Bendlova B Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):192-6. PubMed ID: 16705552 [TBL] [Abstract][Full Text] [Related]
11. RET proto-oncogene mutations are restricted to codons 634 and 918 in mainland Chinese families with MEN2A and MEN2B. Zhou Y; Zhao Y; Cui B; Gu L; Zhu S; Li J; Liu J; Yin M; Zhao T; Yin Z; Yu C; Chen C; Wang L; Xiao B; Hong J; Zhang Y; Tang Z; Wang S; Li X; Ning G Clin Endocrinol (Oxf); 2007 Oct; 67(4):570-6. PubMed ID: 17573899 [TBL] [Abstract][Full Text] [Related]
12. Change in the spectrum of RET mutations diagnosed between 1994 and 2006. Frank-Raue K; Rondot S; Schulze E; Raue F Clin Lab; 2007; 53(5-6):273-82. PubMed ID: 17605401 [TBL] [Abstract][Full Text] [Related]
13. Mutations in the RET proto-oncogene in medullary thyroid carcinoma. Höppner W Clin Lab; 2007; 53(5-6):283-4. PubMed ID: 17605402 [No Abstract] [Full Text] [Related]
14. Evaluation of potential mechanisms underlying genotype-phenotype correlations in multiple endocrine neoplasia type 2. Mise N; Drosten M; Racek T; Tannapfel A; Pützer BM Oncogene; 2006 Oct; 25(50):6637-47. PubMed ID: 16715139 [TBL] [Abstract][Full Text] [Related]
15. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal. Prazeres HJ; Rodrigues F; Figueiredo P; Naidenov P; Soares P; Bugalho MJ; Lacerda M; Campos B; Martins TC Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668 [TBL] [Abstract][Full Text] [Related]
16. The RET p.G533C mutation confers predisposition to multiple endocrine neoplasia type 2A in a Brazilian kindred and is able to induce a malignant phenotype in vitro and in vivo. Oliveira MN; Hemerly JP; Bastos AU; Tamanaha R; Latini FR; Camacho CP; Impellizzeri A; Maciel RM; Cerutti JM Thyroid; 2011 Sep; 21(9):975-85. PubMed ID: 21834681 [TBL] [Abstract][Full Text] [Related]
17. [Multiple endocrine neoplasia type 2A, type 2B and familial medullary thyroid carcinoma syndrome]. Obara T; Yamashita T; Kanbe M; Ito Y; Egawa S; Yamaguchi K Nihon Rinsho; 1995 Nov; 53(11):2708-15. PubMed ID: 8538031 [TBL] [Abstract][Full Text] [Related]
18. RET receptor signaling: dysfunction in thyroid cancer and Hirschsprung's disease. Asai N; Jijiwa M; Enomoto A; Kawai K; Maeda K; Ichiahara M; Murakumo Y; Takahashi M Pathol Int; 2006 Apr; 56(4):164-72. PubMed ID: 16634961 [TBL] [Abstract][Full Text] [Related]
19. Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship. Yip L; Cote GJ; Shapiro SE; Ayers GD; Herzog CE; Sellin RV; Sherman SI; Gagel RF; Lee JE; Evans DB Arch Surg; 2003 Apr; 138(4):409-16; discussion 416. PubMed ID: 12686527 [TBL] [Abstract][Full Text] [Related]
20. RET oncogene mutations in 75 cases of familial medullary thyroid carcinoma in Japan. Kameyama K; Okinaga H; Takami H Biomed Pharmacother; 2004; 58(6-7):345-7. PubMed ID: 15271413 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]